1. A 45-year-old male returns for a follow-up visit. His initial visit blood pressure was 142/92 mm Hg. Today, after resting for five minutes, his average blood pressure is 146/94 mm Hg. He has no other known medical conditions. Which of the following is the most appropriate diagnosis?
Answer: A
The diagnosis of hypertension requires an average of two or more properly measured readings obtained on two or more separate clinical occasions. According to the ACC/AHA hypertension guidelines, a systolic reading of 140 mm Hg or higher, or a diastolic reading of 90 mm Hg or higher, establishes a diagnosis of Stage 2 hypertension. Because this patient has consistent readings above the 140/90 mm Hg threshold across two separate visits, Stage 2 is the correct classification. Stage 1 applies to systolic readings of 130 to 139 or diastolic readings of 80 to 89. Elevated blood pressure requires a systolic of 120 to 129 and a diastolic below 80. Masked hypertension occurs when office readings are normal but out-of-office readings are elevated, which contradicts this patient's clinical presentation.
2. The caregiver of an eighty-five-year-old with advanced heart failure asks when they should notify the clinic regarding the patient's daily weights. The patient's weight fluctuates daily by one to two pounds. What is the best instruction?
Answer: A
Standard heart failure self-management guidelines dictate that a weight gain of 2 to 3 pounds in a single day, or five pounds in a week, is a sensitive indicator of acute fluid retention requiring clinical intervention. A one-pound daily fluctuation is normal and does not warrant a clinic call. Mild dependent ankle swelling by evening is a common chronic finding and is less reliable for acute changes than daily morning weights. Unchanged daily weights indicate stability and successful fluid management.
3. A 55-year-old female has been taking pravastatin 40 mg daily for six months. She presents to the clinic reporting two weeks of unusual fatigue, anorexia, and right upper quadrant fullness. Her physical examination reveals mild scleral icterus. Which action should the nurse practitioner take?
Answer: B
While routine liver monitoring is not recommended for asymptomatic patients, this patient is presenting with unusual fatigue, anorexia, and right upper quadrant fullness, along with scleral icterus. These are clear clinical indicators of potential liver injury. Because she is taking pravastatin 40 mg daily, the nurse practitioner must immediately order a hepatic panel to evaluate for statin-induced hepatotoxicity. Reassuring her that these are transient side effects (Option A) is dangerous and ignores signs of organ damage. Switching to a different agent (Option C) without first confirming and quantifying the liver injury is inappropriate management. Recommending she take the medication at bedtime (Option D) addresses nausea superficially but fails to investigate the underlying, potentially severe hepatic pathology causing her symptoms.
4. A 78-year-old patient with type 2 diabetes is currently taking glipizide 10 mg daily. During a telehealth visit, the patient's daughter reports that her father has had recurrent episodes of confusion and diaphoresis before lunch over the past two weeks. Which intervention is most appropriate?
Answer: A
The patient is experiencing classic symptoms of hypoglycemia, which is a major risk when using sulfonylureas like glipizide in a 78-year-old patient. Discontinuing the sulfonylurea and starting a DPP-4 inhibitor provides effective glycemic control with a minimal risk of hypoglycemia. Option B is incorrect because adding pioglitazone increases fracture and heart failure risks in older adults without resolving the primary issue. Option C is incorrect because basal insulin also carries a significant risk of hypoglycemia and requires complex monitoring. Option D is inappropriate because treating medication-induced hypoglycemia with extra caloric intake leads to weight gain and fails to address the underlying pharmacological mismatch.
5. A 68-year-old male with chronic heart failure experiences recurrent mild fluid overload despite strict adherence to his daily bumetanide. He frequently eats canned soups and frozen meals due to limited mobility. Which management strategy is the most appropriate next step?
Answer: D
Educating the patient on sodium restriction addresses the root cause of his recurrent volume overload, which is a fundamental tertiary prevention intervention. His reliance on highly processed foods introduces excessive sodium that negates the diuretic's efficacy. Option D directly tackles this lifestyle factor. Option A prematurely increases medication without addressing the underlying dietary non-adherence. Option B is too aggressive for mild overload and skips basic dietary optimization. Option C does not resolve the fluid overload or address the excessive dietary sodium intake.
6. A 60-year-old male is initiated on rosuvastatin 20 mg daily for primary prevention of cardiovascular disease. He asks when he should return to evaluate the medication's effectiveness and check his fasting lipid panel. What is the best response?
Answer: A
The AHA/ACC guidelines recommend checking a fasting lipid panel 4 to 12 weeks after initiating statin therapy to assess therapeutic response and medication adherence. Option A is correct because eight weeks falls perfectly within this recommended window. Option B and Option C are incorrect because waiting six months or a year delays the opportunity to adjust the dose if the LDL-C reduction is inadequate. Option D is incorrect because two weeks is generally too early to observe the maximum therapeutic effect of the newly initiated statin therapy.
7. A 58-year-old Caucasian male with uncomplicated hypertension returns for follow-up. He currently takes benazepril 40 mg daily but his average blood pressure remains 146/92 mmHg. His basic metabolic panel is completely within normal limits.
Answer: A
When a patient requires a second medication to achieve blood pressure goals, guidelines recommend combining agents from different first-line classes, such as adding a calcium channel blocker or thiazide diuretic to an ACE inhibitor. Adding amlodipine provides a complementary mechanism of action and improves control. Adding losartan is contraindicated because combining an ACE inhibitor with an ARB increases the risk of hyperkalemia and renal dysfunction. Clonidine and metoprolol are not first-line agents and should only be used for specific compelling indications or resistant hypertension.
8. A 50-year-old male with uncomplicated essential hypertension was started on metoprolol succinate 50 mg daily three months ago. His blood pressure remains 148/94 mmHg, and his heart rate is 58 bpm. Which intervention is most appropriate?
Answer: C
Beta-blockers are no longer recommended as first-line therapy for uncomplicated essential hypertension because they demonstrate inferior cardiovascular outcomes, particularly regarding stroke prevention, when compared to other major antihypertensive classes. This patient currently has uncontrolled blood pressure and is already experiencing bradycardia, making any dose increase highly inappropriate. Adding a non-dihydropyridine calcium channel blocker is strictly contraindicated due to the severe risk of profound bradycardia or heart block when combined with a beta-blocker. Tapering the metoprolol and starting a preferred first-line agent, such as an angiotensin converting enzyme inhibitor, is the most appropriate evidence-based intervention. Continuing the beta-blocker and adding a diuretic leaves the patient on a suboptimal primary agent.
9. A 72-year-old female with chronic heart failure reports a three-pound weight gain over the past two days. She denies orthopnea or paroxysmal nocturnal dyspnea but notices mild ankle swelling. Her current blood pressure is 118/74 mmHg. Which intervention best demonstrates tertiary prevention?
Answer: B
Implementing a diuretic action plan for a sudden weight gain without severe symptoms is a vital tertiary prevention strategy to manage fluid status and prevent hospitalization. Option B empowers the patient to self-manage early congestion safely at home. Option A is an overreaction since she lacks acute respiratory distress or hemodynamic instability. Option C is harmful because beta-blockers are essential for long-term survival and should never be stopped for mild volume overload. Option D delays necessary immediate intervention for the fluid accumulation and does not actively manage the congestion.
10. A 72-year-old male with heart failure takes digoxin 0.125 mg daily. He recently started furosemide 40 mg daily for worsening edema. He now reports new-onset anorexia and nausea over the past three days.
Answer: A
Hypokalemia from loop diuretics like furosemide increases the risk of digoxin toxicity, which often presents early as anorexia and nausea. Obtaining serum potassium and digoxin levels evaluates this suspected adverse pharmacotherapeutic outcome. Option B is incorrect because stopping furosemide abruptly exacerbates heart failure without confirming the underlying issue. Option C masks the symptoms of toxicity. Option D does not address the potential life-threatening toxicity or electrolyte imbalance.
11. An 82-year-old female completes the Timed Up and Go (TUG) test in 15 seconds. She has a history of mild cognitive impairment and hypertension.
Answer: C
A TUG score of 12 seconds or greater indicates an increased risk for falls. The appropriate next step is a multifactorial fall risk assessment, which includes reviewing medications for side effects and checking for postural hypotension, making Option C correct. Option A is incorrect because 15 seconds is abnormal and requires intervention, regardless of age. Option B is premature; while she may eventually need a device, identifying reversible causes like medication effects or orthostasis comes first. Option D is incorrect because restricting activity leads to deconditioning, which paradoxically increases fall risk; maintaining safe mobility is preferred.
12. A 45-year-old patient with major depressive disorder is prescribed venlafaxine. At 75 mg daily, the patient reports no improvement in energy. The FNP increases the dose to 225 mg daily. The patient returns reporting improved energy but new-onset resting blood pressure of 148/92 mmHg.
Answer: A
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor, but its pharmacodynamics are highly dose-dependent. At lower doses, it acts almost exclusively as a serotonin reuptake inhibitor. When the dose is increased above 150 mg daily, it begins to exert significant norepinephrine reuptake inhibition, which improves energy and concentration but can also cause dose-dependent hypertension. Option A correctly identifies this mechanism linked to the patient's new-onset elevated blood pressure. Option B is incorrect because receptor down-regulation explains delayed therapeutic onset, not acute blood pressure changes. Option C is incorrect as venlafaxine lacks significant dopamine reuptake inhibition at these doses. Option D is incorrect because histamine antagonism typically causes sedation and weight gain rather than hypertension, and it is not a primary mechanism of this medication.
13. A 70-year-old patient with a history of heart failure presents stating, “My breathing gets bad when I lie flat.” The FNP suspects orthopnea. How should the chief complaint be formally documented in the SOAP note?
Answer: C
The chief complaint should ideally be documented using the patient's own words enclosed in quotation marks, as it represents the exact reason for the visit from their perspective. Option C is correct. Option A is incorrect because it translates the patient's symptom into a formal medical diagnosis, which belongs in the Assessment section. Option B is incorrect as it uses medical terminology and clinical reasoning rather than the patient's direct quote. Option D is incorrect because it interprets the symptom as a clinical syndrome, which is appropriate for the HPI but not the raw chief complaint.
14. 70-year-old male with chronic heart failure shows a weight fluctuation of 0.5 pounds daily and consistent ability to walk one mile.
Answer: A
The patient's log demonstrates excellent clinical stability and euvolemia, as evidenced by minimal weight variance and a highly preserved functional capacity. The best action for you to take is to maintain the current plan without making any unnecessary adjustments. Reducing the daily loop diuretic dosage is risky and unwarranted when the patient is perfectly compensated on their current regimen. Ordering an echocardiogram to assess function is not indicated for routine monitoring of a stable patient who reports no new or worsening symptoms. Recommending a strict fluid restriction protocol is unnecessary, overly restrictive, and burdensome for someone who is already well-managed, asymptomatic, and thriving on their current dietary and pharmacological routine.
15. A 50-year-old male taking atorvastatin 40 mg daily for eight weeks presents with new bilateral thigh aching. His repeat LDL decreased by 55%, but his creatine kinase level is significantly elevated.
Answer: B
The patient presents with statin-associated muscle symptoms accompanied by a significantly elevated creatine kinase, which are red flags for severe myopathy or impending rhabdomyolysis. Option B is correct because the immediate clinical priority is stopping the offending agent to prevent acute kidney injury and assessing for muscle breakdown. Option A is incorrect because it ignores a potentially life-threatening adverse effect. Options C and D are incorrect because you should not continue, reduce, or switch statin therapy until severe myotoxicity is fully ruled out and the patient's creatine kinase levels return to baseline.
